Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (91-100 of 205) with videos related to

Pageof 21
Sort By:
Hepatic Oncology|September 8, 2018
Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinomaNathalie Ganne-Carrié, Jean-Charles Nault, Marianne Ziol, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 18, 2014
Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteriaOlivier Seror, Gisèle N'Kontchou, Jeanne Tran Van Nhieu, et al.
Nutrients|January 11, 2018
Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control StudyCamille Buscail, Valérie Bourcier, Léopold K Fezeu, et al.
The American Journal of Gastroenterology|January 18, 2007
Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis CPierre Nahon, Gabriel Thabut, Marianne Ziol, et al.
Hepatology (Baltimore, Md.)|December 21, 2018
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected PatientsDominique Salmon-Ceron, Pierre Nahon, Richard Layese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2005
Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and deathPierre Nahon, Angéla Sutton, Dominique Pessayre, et al.
Gastroenterologie Clinique Et Biologique|May 3, 2005
Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosisPierre Nahon, Nathalie Ganne-Carrié, Françoise Degos, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2016
The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolizationSamia Rekik, Erwan Guyot, Mohannad Bhais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosisPierre Nahon, Roland Amathieu, Mohamed N Triba, et al.
Radiology|August 18, 2016
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term ResultsOlivier Seror, Gisèle N'Kontchou, Jean-Charles Nault, et al.
Pageof 21

Showing results (91-100 of 205) with videos related to

Sort By:
Pageof 21
Hepatic Oncology|September 8, 2018
Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinomaNathalie Ganne-Carrié, Jean-Charles Nault, Marianne Ziol, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 18, 2014
Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteriaOlivier Seror, Gisèle N'Kontchou, Jeanne Tran Van Nhieu, et al.
Nutrients|January 11, 2018
Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control StudyCamille Buscail, Valérie Bourcier, Léopold K Fezeu, et al.
The American Journal of Gastroenterology|January 18, 2007
Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis CPierre Nahon, Gabriel Thabut, Marianne Ziol, et al.
Hepatology (Baltimore, Md.)|December 21, 2018
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected PatientsDominique Salmon-Ceron, Pierre Nahon, Richard Layese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2005
Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and deathPierre Nahon, Angéla Sutton, Dominique Pessayre, et al.
Gastroenterologie Clinique Et Biologique|May 3, 2005
Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosisPierre Nahon, Nathalie Ganne-Carrié, Françoise Degos, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2016
The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolizationSamia Rekik, Erwan Guyot, Mohannad Bhais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosisPierre Nahon, Roland Amathieu, Mohamed N Triba, et al.
Radiology|August 18, 2016
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term ResultsOlivier Seror, Gisèle N'Kontchou, Jean-Charles Nault, et al.
Pageof 21